Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

AbbVie, Merck & Co., Inc., UnitedHealth Group, Hims & Hers Health, and Insmed are the five Medical stocks to watch today, ...

Find insight on Hims & Hers Health, EssilorLuxottica, Bayer and more in the latest Market Talks covering Health Care.

Investing.com -- Bank of America (NYSE: BAC) has unveiled its top 10 U.S. Ideas for the third quarter of 2025, featuring eight Buy-rated stocks and two Underperform calls across ten industries.

Phibro Animal Health PAHC shares have climbed 52.8% in a year, showcasing impressive momentum. The stock has outpaced the industry’s 14.3% growth and the S&P 500 composite’s 11.7% gain. With healthy ...

Qualivian Investment Partners, an investment partnership focused on long-only public equities, released its Q1 2025 investor ...